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Abstract
Chronic gastritis is one of the common diseases of the digestive system charac-
terized by many uncomfortable clinical symptoms, and the patient with chronic 
gastritis has a lower quality of life. Chinese medicine is a branch of medicine in the 
world, and it has special theory; different methods have been used to treat gastritis 
for more than 1000 years. We aimed to introduce the special theory and the differ-
ent methods of Chinese medicine and about its syndrome classification, syndrome 
differentiation and treatment, diagnosis and treatment process, and criterion of 
therapeutic effect of chronic gastritis. The mechanism of Chinese medicine on 
chronic gastritis needs further research.
Keywords: gastritis, Chinese medicine, diagnosis, syndrome classification, syndrome 
differentiation, treatment
1. Introduction
Chronic gastritis is one of the common diseases of the digestive system and a 
chronic inflammatory reaction of gastric mucosa caused by several factors, such as 
Helicobacter pylori infection, alcoholism, smoking, stress conditions, and the use of 
some conventional medicines such as some anti-inflammatory drugs; the infection 
of Helicobacter pylori is its main cause [1, 2]. Chronic non-atrophic gastritis, atro-
phic gastritis (atrophy, intestinal metaplasia), dysplasia, and carcinogenesis may 
occur after Helicobacter pylori infection [3, 4].
Chronic gastritis is usually divided into chronic superficial gastritis and chronic 
atrophic gastritis. Chronic superficial gastritis is characterized by no obviously 
pathological changes. Its common symptoms are abdominal discomfort after eating, 
dull pain, accompanying belching, and pantothenic acid. Chronic atrophic gastritis 
is characterized by atrophy and decrease of gastric mucosal epithelium and glands, 
thinness of gastric mucosa, thickening of the mucosal base, or metaplasia of pyloric 
gland and intestinal gland or atypical hyperplasia. Chronic atrophic gastritis occurs 
in approximately 2% of the general population in the United States [5], particu-
larly those older than 60 years and with higher prevalence in females [5, 6], and a 
Swedish study reported an increased incidence in the population aged between 35 
and 45 years [6]. The common symptoms of chronic gastritis are a dull pain in the 
upper abdomen, abdominal fullness and distention, belching, inappetence, or being 
thin and anemic. The symptoms of gastritis are easy to relapse which seriously 
affect their quality of life. Chronic atrophic gastritis with intestinal metaplasia and 
intraepithelial neoplasia increases the risk of gastric cancer, and more attention has 
been paid to gastritis clinically.
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Traditional Chinese medicine (TCM) has accumulated many years of clinical 
experience in the diagnosis and treatment of this disease. In 2009, spleen-stomach 
disease branch of China Association of Chinese Medicine (CACM) organized and 
formulated the “consensus opinions on TCM diagnosis and treatment of chronic 
superficial gastritis” and “consensus opinions on TCM diagnosis and treatment of 
chronic atrophic gastritis,” which played a normative role in the diagnosis and treat-
ment of chronic gastritis. In recent years, there are a lot of progress of TCM in the 
diagnosis and treatment of chronic gastritis. It is necessary to update the consensus 
opinions to meet clinical needs and better guide clinical work.
Based on the principles of evidence-based medicine, team members of spleen-
stomach disease branch of CACM extensively collected evidence-based information, 
and they successively organized domestic experts of spleen and stomach diseases to 
summarize and discuss a series of key issues such as syndrome classification, syn-
drome differentiation and treatment, diagnosis and treatment process, and criterion 
of therapeutic effect for chronic gastritis. Based on an expert opinion, three rounds 
of voting followed under internationally accepted Delphi law, the drafting group has 
fully discussed, revised, and approved the consensus in 2017 (Consensus opinions of 
TCM diagnosis and treatment experts on chronic gastritis, 2017 edition) [7].
2. TCM diagnosis of chronic gastritis
TCM diagnosis of chronic gastritis is mainly based on symptom diagnosis. 
Patients with stomachache as the main symptom were diagnosed as “epigastric 
pain,” and patients with epigastric distention as the main symptom were diagnosed 
as “distention and fullness.” If the symptoms of stomachache or epigastric disten-
tion are not obvious, it can be diagnosed as “acid regurgitation,” “hubbub,” and 
other diseases according to the main symptoms [8, 9].
3. Diagnosis of chronic gastritis by western medicine
The diagnosis of chronic gastritis mainly depends on endoscopy and pathologi-
cal examination, especially the latter is of greater value. The etiology of chronic 
gastritis should be determined as far as possible, and endoscopic diagnosis of 
special gastritis must combine etiology and pathology [10].
3.1 Clinical manifestations
Chronic gastritis is a chronic inflammatory reaction of the gastric mucosa, 
and most patients with chronic gastritis may have no obvious clinical symptoms. 
Patients with symptoms mainly manifested a non-specific dyspepsia, such as 
discomfort in the upper abdomen, fullness, pain, loss of appetite, belching, acid 
regurgitation, etc. A part also can have forgetfulness, anxiety, depression, and other 
psychological symptoms [8–10]. There was no significant correlation between the 
presence and severity of dyspepsia and the histological findings and endoscopic 
grading of chronic gastritis [8–10].
3.2 Endoscopic and pathological examination
Endoscopic diagnosis: For non-atrophic gastritis, endoscopic examination showed 
the basic manifestations of mucosal erythema, mucosal hemorrhagic spots or plaques, 
rough mucosa with or without edema, hyperemia, and exudation. For atrophic 
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gastritis, endoscopic examination showed that the mucosa was red and white, mainly 
white, with folds flattened or even disappeared. Some mucosal vessels were exposed, 
which may be accompanied by mucosal granules or nodules. It is described as atrophic 
gastritis or non-atrophic gastritis with bile reflux, erosion and mucosal bleeding, etc.
Histopathologic diagnosis: Two or more biopsy tissues can be selected as required. 
The endoscopic physician should provide the site of sampling, endoscopic examina-
tion results, and brief medical history to the pathology department. The pathological 
changes should be reported in each biopsy specimen in each biopsy specimen, such 
as the grade of Helicobacter pylori infection, chronic inflammatory response, activity, 
atrophy, intestinal metaplasia, and dysplasia (intraepithelial neoplasia). Chronic 
gastritis biopsy shows atrophy of the inherent glands (including metaplasia atrophy 
and non-metaplasia atrophy), which can be diagnosed as atrophic gastritis, regard-
less of the number and degree of atrophy of the biopsy specimen. The clinician may 
combine the pathological result and the endoscopic view, making the lesion scope and 
the degree judgment [10].
3.3 Lab examination
Helicobacter pylori is the most important cause of chronic gastritis. Routine 
detection is recommended. Vitamin B12 and autoantibodies are recommended for 
diagnosis of atrophic gastritis. Serum gastrin G17, pepsin I and II may help deter-
mine whether gastric mucosa atrophy and atrophy [10].
4. Etiology and pathogenesis of chronic gastritis
4.1 Etiology
The stomach is physiologically harmonious, but pathologically it is sluggish [11]. 
This disease is mainly related to the weakness of spleen and stomach, emotional 
disorders, improper diet, drugs, exogenous pathogens (Helicobacter pylori infec-
tion), and other factors; the above factors damage the spleen and stomach, resulting 
in transport and loss of division, rise and fall disorders, and the occurrence of Qi 
stagnation, wet resistance, cold coagulation, fire depression, blood stasis, etc., 
manifested as stomachache, bloating, and other symptoms.
4.2 Disease location
Chronic gastritis is located in the stomach and is closely related to the liver and 
spleen in TCM theory.
4.3 Pathogenesis
The pathogenesis of chronic gastritis can be divided into two aspects: deficient 
essential and excessive superficial. This deficiency is mainly manifested as qi 
(Yang) deficiency and stomach yin deficiency. The main manifestations of exces-
sive superficial are stagnation of qi, dampness and heat, and blood stasis. Spleen 
deficiency and qi stagnation are the basic pathogenesis of chronic gastritis.
4.4 Change of pathogenesis
The syndrome differentiation of chronic gastritis should examine the evidence and 
seek the cause. The pathogenesis is related to the specific clinical type. In general, it is 
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often clinically manifested as the syndrome of the combination of the original and the 
false and the real [8, 9]. In the early stage, the patients were mainly positivistic, while 
the patients who had been ill for a long time became the deficiency syndrome or the 
mixture of deficiency and reality. Chronic non-atrophic gastritis is characterized by 
weakness of the spleen and stomach and disharmony of the liver and stomach [12]. 
Chronic atrophic gastritis is characterized by weakness of the spleen and stomach, qi 
stagnation, and blood stasis [13, 14]. Chronic gastritis with bile reflux is more common 
with disharmony between the liver and stomach [15]. Spleen and stomach dampness-
heat syndrome is common in patients with Helicobacter pylori infection [16, 17]. For 
patients with precancerous lesions, qi and yin deficiency, qi stagnation and blood 
stasis, and damp-heat internal obstruction syndromes are common [18, 19].
5. Syndrome differentiation type of chronic gastritis
Combined with existing consensus and standards, quantitative literature statisti-
cal methods were used to conduct statistics on the relatively common clinical single 
syndromes. The common syndromes were identified as the syndrome of liver- 
stomach disharmony which includes the syndrome of liver-stomach qi stagnation 
and the syndrome of liver-stomach heat retention, the syndrome of damp-heat of 
the spleen and stomach, the syndrome of spleen-stomach weakness including the 
syndrome of spleen-stomach qi deficiency and the syndrome of spleen-stomach cold 
syndrome, the syndrome of deficiency of stomach yin, and the syndrome of obstruc-
tion of stomach collaterals. The above syndromes can appear alone or in combination, 
and the clinical diagnosis should be based on the identification of single syndromes.
5.1 Standard of syndrome differentiation
5.1.1 Syndrome of liver-stomach disharmony
5.1.1.1 Syndrome of liver-stomach qi stagnation
Main symptoms are full or painful epigastric distention, distension, or pain in 
the flanks. Minor symptoms are induced or exacerbated by emotional factors and 
frequent belching. Symptoms in the tongue and pulse include pink tongue, thin and 
white moss, and wiry pulse.
5.1.1.2 Syndrome of liver-stomach heat retention
Main symptoms are epigastric burning pain, distension, or pain in the flanks. 
Minor symptoms are upset and irritability, acid reflux, dry mouth, bitter mouth, 
and dry stool. Symptoms in the tongue and pulse include red tongue, yellow moss, 
wiry pulse, or rapid pulse.
5.1.2 Syndrome of damp-heat of the spleen and stomach
Main symptoms are distention and fullness of stomach and abdomen, 
trapped and heavy body, and loose or sticky stool. Minor symptoms include 
eating less, anorexia, bitter mouth, bad breath, and drowsy mental. Symptoms 
in the tongue and pulse include red tongue, yellow and greasy moss, slippery 
pulse, or rapid pulse.
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5.1.3 Weakness of the spleen and stomach
5.1.3.1 Syndrome of spleen-stomach qi deficiency
Main symptoms are epigastric distension or faint stomachache, postprandial 
aggravation, tired, and weak. Minor symptoms are indigestion and loss of appetite, 
cold limbs, and thin and sloppy stool. Symptoms in the tongue and pulse include 
pale tongue or tooth marks, thin and white moss, and weak pulse.
5.1.3.2 Syndrome of deficiency of the spleen and stomach
The main symptom is dull and insistent stomachache, preferring warmth and 
pressure. Minor disease: stomachache attack or aggravation after fatigue or take 
cold, spit water, mental fatigue, limb lassitude, diarrhea or with indigestible food. 
Symptoms in the tongue and pulse include pale and fat tongue with tooth mark, 
white and slippery moss, and deep and weak pulse.
5.1.4 Syndrome of deficiency of stomach yin
Major symptoms include epigastric burning pain and noise in the stomach. 
Minor symptoms include hunger and not wanting to eat, dry mouth, and dry stool. 
Symptoms in the tongue and pulse include red tongue and little saliva, no or little 
moss, and thin or rapid pulse.
5.1.5 Syndrome of stomach collateral stasis
Main symptoms are fullness in the stomach or pain with definite location. 
Minor symptoms are stomach pain for a long time and sting pain. Symptoms in the 
tongue and pulse include dark red tongue or petechiae, ecchymosis, and wiry and 
unsmooth pulse.
Syndrome diagnosis: with two main symptoms and two minor symptoms, the 
diagnosis can be made by referring to tongue and pulse.
5.2 Microscopic syndrome differentiation of chronic gastritis
Gastroscope is a tool to observe the color, texture, secretion, peristalsis of gas-
tric mucosa, and mucosal blood vessels to identify the type of syndrome differ-
entiation. Syndrome differentiation under gastroscopy has certain clinical value, 
especially for patients with no clinical symptoms or poor efficacy after long-term 
treatment. The classification standards of microscopic syndrome differentiation 
are as follows [20].
5.2.1 Syndrome of disharmony between liver and stomach
Syndromes are acute and active inflammatory reaction in gastric mucosa, or 
with bile reflux, gastric peristalsis faster.
5.2.2 Syndrome of spleen-stomach dampness and heat
Syndromes are congestion and edema in gastric mucosa and obvious erosion of 
thick and turbid mucus.
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5.2.3 Syndrome of spleen-stomach weakness
Syndromes include pale gastric mucosa, thinning mucosa, thin and more mucus 
or mucosal edema, visible submucosal blood vessels, and decreased gastric motility.
5.2.4 Syndrome of stomach yin deficiency
Syndromes are rough mucosal surface, thin and brittle, less secretion, thinner or 
disappeared plica, fissure-like changes, or visible small vascular network under the 
mucous membrane.
5.2.5 Syndrome of stomach collateral stasis
Syndromes are granular or nodular gastric mucosa, with intramucosal hemor-
rhage; gray or brown mucus; visible vascular network; and dark red vascular veins.
6. Clinical treatment of chronic gastritis
The main aim to treat chronic gastritis with traditional Chinese medicine focuses 
on improving the symptoms and quality of life of the patients and paying close 
attention to the lesions of erosion and atrophy of gastric mucosa, intestinal meta-
plasia, and intraepithelial neoplasia (dysplasia).
6.1 Therapeutic principles
The main therapeutic methods of TCM for chronic gastritis include medica-
tion, acupuncture, moxibustion therapy, etc. In clinic, appropriate treatment 
methods can be selected according to the specific situation and combined with 
dietary adjustment, psychological counseling, and other methods of comprehensive 
treatment. In the course of treatment, etiologic factors based on differentiation and 
treatment based on syndrome differentiation should be determined.
6.2 Treatment based on syndrome differentiation
6.2.1 Syndrome of disharmony between the liver and stomach
6.2.1.1 Syndrome of qi stagnation between the liver and stomach
The therapeutic principle is to soothe the liver to smoothen qi and harmonize the 
stomach. Main prescription includes Chaihu Shugan powder (Jingyue Quanshu). Chinese 
herbal medicine include Bupleurum, tangerine peel, Fructus aurantii, peony, Rhizoma 
cyperi, Ligusticum striatum, and liquorice. Patient with epigastric pain can add Sichuan 
neem seed and Rhizoma corydalis. Patient with apparent belch can add agarwood and 
inula flower.
6.2.1.2 Syndrome of heat stagnation in the liver and stomach
Treatment includes cooling the liver and soothing the stomach. Main prescrip-
tion includes Huagan decoctum (Jingyue Quanshu) and Zuo Jin Wan (Danxi Xinfa). 
Medication includes Pericarpium citri reticulatae viride, tangerine peel, white 
peony root, peony peel, Gardenia, Alisma, fritillary bulb of Zhejiang, Rhizoma cop-
tidis, and Evodia officinalis. Patient with obvious acid reflux can add squid bone and 
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concha arcae. Patient with fullness and discomfort in the chest and hypochondrium 
can add Bupleurum and Radix curcumae.
6.2.2 Syndrome of damp-heat in the spleen and stomach
Treatment includes clearing heat and removing dampness. Main prescription 
includes the soup of Huanglian Wendan (Discrimination of Six Causes). Chinese 
herbal medicine include Pinellia ternata, orange peel, Poria cocos, immature bitter 
orange, bamboo shavings, Rhizoma coptidis, jujube, and liquorice. Patient with 
abdominal distension can add Magnolia officinalis and betel nut. Patient with belch-
ing acid decay can add radish seed, Divine comedy, and hawthorn.
6.2.3 Syndrome of deficiency of the spleen and stomach
6.2.3.1 Syndrome of the spleen and stomach qi deficiency
Treatment includes reinforcing qi to strengthen the spleen. Main prescrip-
tion includes Xiangsha Liujunzi decoction (Ancient and Modern Famous Medical 
Prescription). Chinese herbal medicine includes costustoot, orange peel, Pinellia 
ternata, Codonopsis, Atractylodes, Poria cocos, and liquorice. Patient with fullness 
and distention can add citron. Patient with shortness of breath and sweating can 
add Radix Astragali Preparata. Patient with cold limbs can add cassia twig and 
Angelica.
6.2.3.2 Syndrome of deficiency and cold in spleen and stomach
Treatment includes warming and strengthening the spleen. Prescription 
includes Huangqi Jianzhong decoction (Synopsis of the Golden Chamber) and 
Lizhong decoction (Treatise on Febrile Diseases). Chinese herbal medicines 
include Astragalus, peony, cassia twig, ginger, jujube, maltose, Codonopsis, white 
Atractylodes rhizome, dried ginger, and liquorice. Patient with loose stool can add 
cannon ginger charcoal and fried coix seed. Patient with obvious chills can add 
aconite.
6.2.4 Syndrome of yin deficiency of stomach
Treatment includes nourishing yin, benefiting the stomach. The main prescrip-
tion is Yiguan Decoction (Xu Mingyi Lei’an). Chinese herbal medicines include 
radix ginseng, Radix ophiopogonis, Rehmanniae, Angelica sinensis, Fructus lycii, 
and Szechwan Chinaberry fruit. Patient with obvious stomachache can add Paeonia 
lactiflora and liquorice. Patient with constipation can add snake gourd fruit and 
semen cannabis.
6.2.5 Syndrome of stomach collaterals stasis
The treatment includes activating blood circulation and removing blood sta-
sis. Main prescription includes Shixiao powder (Taiping Huimin Heji Jufang) and 
Danshen decoction (Shifang Gekuo). Chinese herbal medicines include Wuling zhi, 
Typhae pollen, Salvia miltiorrhiza, Sandalwood, and Amomum. Patient with obvi-
ous pain can add Rhizoma corydalis and Radix curcumae. Patient who has shortness 
of breath and is weak can add Astragalus and Codonopsis. For patients with complex 
clinical symptoms and multiple syndromes, the combination of prescriptions 
corresponding to the pathogenesis can improve the treatment effect. For example, 
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if the pathogenesis of gastritis patient is the deficiency of the spleen and stomach 
and the disharmony between the liver and stomach, the main prescription should 
be Xiangsha Liujunzi decoction and Bupleurum Shugan powder.
6.3 Treatment based on disease differentiation
Treating chronic gastritis by disease differentiation is an important part of 
TCM clinical practice. The principle is to formulate the prescription based on the 
understanding of the basic pathogenesis of chronic gastritis and then prescribe the 
prescription according to the syndrome. From the composition of clinical prescrip-
tions, most of them are composed of single syndrome prescriptions. For those 
without obvious clinical symptoms, treatment can be carried out based on disease 
differentiation combined with the syndrome differentiation results of the tongue 
and pulse and gastric mucosa manifestation under endoscope.
In chronic gastritis patients with positive Helicobacter pylori, eradication of 
Helicobacter pylori is necessary if there are obvious clinical symptoms or accompa-
nied by atrophy, erosion, intestinal metaplasia, intraepithelial neoplasia, or family 
history of gastric cancer [8, 10]. The eradication of Helicobacter pylori guidelines 
and drug regimen were need.
Based on the syndrome differentiation, when chronic gastritis is accompanied 
by gastric mucosa congestion and erosion, Notoginseng powder, Rhizoma bletillae 
powder, and Pearl powder can be added for treatment, and it can be taken with 
decoction or with warm water after making a paste and taken on an empty stomach. 
For patients with intramucosal hemorrhage, the herbs to remove blood stasis and 
stop bleeding can be added, such as Panax notoginseng powder and Rhizoma bletillae 
powder. For chronic gastritis patient with precancerous lesions and syndrome of 
non-spleen-stomach deficient cold can add Hedyotis diffusa, Scutellariae barbatae, 
and Chinese lobelia into the compound prescription or use the herbs for promoting 
circulation and removing stasis, such as Salvia miltiorrhiza, Panax notoginseng, and 
Zedoary turmeric.
6.4 Commonly used Chinese patent medicine
6.4.1 Qizhi Weitong granules
It can smooth liver qi and harmonize the stomach to alleviate stomachache. It 
was usually used for patients with depression or irritability, sigh, belching, chest 
stuffiness and fullness, and epigastric pain.
6.4.2 Weishu granules
It can regulate qi and eliminate distension and alleviate stomachache. It was 
usually used for patients with epigastric pain caused by qi stagnation with epigastric 
distension pain, which extends to two sides, pain relief after belching or flatus, pain 
aggravation after emotional depression and anger, eating less food, chest distress, 
and poor defecation.
6.4.3 Wenweishu capsule
It can nourish the stomach and promote Qi circulation to relieve pain. It was usu-
ally used for patients with stomachache caused by deficiency and cold in the middle 
Jiao with epigastric cold pain, abdominal distension and belching, poor appetite, 
less food, intolerance of cold, and weakness.
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6.4.4 Xuhan Weitong granule
It can tonify Qi and the spleen and warm the stomach to relieve pain. It is usually 
used for patients with stomachache caused by deficiency of the spleen and stomach. 
The symptoms are epigastric dull pain, tolerance of warmth and pressure, aggrava-
tion after catch cold, eating cold food, or stomach empty.
6.4.5 Jianwei Xiaoshi oral liquid
It can tonify the stomach and improves digestion. It was usually used for patients 
with dyspepsia caused by deficiency of the spleen and stomach. The symptoms are 
dyspepsia, belching, putrid belching and acid swallowing, abdominal fullness, and 
distention.
6.4.6 Yangweishu capsule
It can nourish the yin and stomach. It was usually used for patients with epigas-
tric burning pain caused by deficiency of the yin and stomach. The further symp-
toms are dull pain, feverishness in palms and soles, dry mouth, bitter mouth, poor 
appetite, and emaciation.
6.4.7 Cubeb Weitong granules
It can activate Qi to promote blood circulation and harmonize stomach to relieve 
pain. It was usually used for epigastric distension and pricking pain caused by Qi 
stagnation and blood stasis.
6.4.8 Molodan (concentrated pills)
It can harmonize the stomach and calms the adverse-rising energy, strengthens 
the spleen to relieve distension and dredge collateral to relieve pain. It was usually 
used for patients with symptoms of stomachache, fullness, stuffy, indigestion, and 
loss of appetite and belching.
6.4.9 Wei Fuchun capsule
It can strengthen the spleen and nourish qi and promote blood circulation and 
detoxification. It was usually used for patients with the precancerous lesions of gastric 
cancer of chronic atrophic gastritis or adjuvant treatment after gastric cancer surgery.
6.4.10 Dalitong granules
It can clear heat and relieve depression, regulate the stomach and calm the adverse-
rising energy, and eliminate stagnation. It was usually used for patients with epigastric 
fullness and distention syndrome caused by heat stagnation of the liver and stomach. 
The symptoms include epigastric distension and fullness, belching, poor appetite, 
heartburn in the stomach, noisy pantothenic acid, epigastric pain, and dry and bitter 
mouth. The dyskinetic type of functional dyspepsia seen above symptoms.
6.4.11 Weitai granules
It can promote Qi circulation and relieve stomachache. It is usually used for 
patients with stomachache caused by qi stagnation and blood stasis and dampness 
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and heat stasis. The symptoms are abdominal dull pain, fullness, sour regurgitation, 
nausea, and vomiting; the discomfort is lessened after eating.
6.4.12 Jin Weitai capsule
It can promote qi circulation and relieve pain in the stomach. It is usually 
used for patients with acute and chronic gastroenteritis, ulcer in the stomach and 
duodenum caused by qi stagnation of the liver and stomach or dampness and 
heat stasis.
6.4.13 Weikang capsule
It can promote Qi circulation and invigorate the stomach, remove blood stasis 
and hemostasis, and relieve hyperacidity and pain. It is usually used for patients 
with epigastric pain caused by Qi stagnation and blood stasis. The further symp-
toms are pain fixation, acid swallowing noise, and gastric and duodenal ulcers.
6.4.14 Jinghua Weikang Jiaowan
It can regulate Qi to dissipate cold and clear heat and disperse blood stasis. It is 
usually used for patients with epigastric distension pain or duodenal ulcer caused by 
mixed coldness and heat syndrome and Qi stagnation and blood stasis and belch-
ing; the further symptoms are acid regurgitation, noise, and bitter mouth.
6.4.15 Ganhai Weikang capsule
It can strengthen the spleen and stomach and relieve pain with convergence. It 
was usually used for patients with chronic gastritis stomach and duodenal ulcer and 
reflux esophagitis caused by spleen deficiency and qi stagnation.
6.4.16 Dongfang Weiyao capsule
It can soothe the liver and harmonize stomach, regulate Qi and promote blood 
circulation, clear heat, and relieve pain. It is usually used for patients with epigastric 
pain caused by liver-stomach disharmony and heat stasis blocking collaterals; the 
symptoms are stomachache, belching, acid swallowing, noise, poor appetite, and 
irritability.
6.4.17 Yanshen Jianwei capsule
It can strengthen the spleen and harmonize the stomach, regulate cold and heat, 
and relieve fullness and pain. It was usually used for patients with stomachache 
caused by deficiency in origin and enrichment in symptom and mixed coldness and 
heat; the symptoms are epigastric fullness, stomachache, poor appetite, belching, 
noise, fatigue, and weakness.
6.4.18 Danweikang capsule
It can soothe the liver and gallbladder and clear dampness and heat. It was usu-
ally used for patients with hypochondriac pain and jaundice caused by the damp-
heat in the liver and gallbladder. It can also be used for patients with bile reflux 
gastritis and cholecystitis that have the same symptoms.
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6.5 Acupuncture and moxibustion therapy
Acupuncture and moxibustion therapy have an effect on improving the symp-
toms of chronic gastritis. Acupuncture and moxibustion can effectively relieve the 
symptoms of gastritis in patients with syndrome of deficiency of the spleen and 
stomach and improve their quality of life [21–24].
Acupoints in acupuncture treatment include Zusanli (ST36), Zhongwan (RN12), 
Weishu (BL21), Pishu (BL20), and Neiguan (PC6). Patient with liver-stomach dishar-
mony syndrome plus Ganshu (BL17), Taichong (LR4), Qimen (LR14). Patient with 
hot stasis syndrome plus Tianshu (ST25), Fenglong (ST40). Patient with weakness 
of spleen and stomach syndrome should add Pishu (BL20), Liang qiu (ST34), Qihai 
(RN6). Patient with deficiency of stomach Yin syndrome should add Sanyinjiao (SP6), 
Taixi (KI3). For those with severe cold and deficiency of spleen and stomach syn-
drome, moxibustion should be performed at Shangwan (RN13), Zhongwan (RN12), 
Xiawan (RN10), and Zusanli (ST36). Patient with nausea, vomiting, or belching 
should add Shangwan (RN13), Neiguan (PC6), Geshu (BL17). Patient with severe 
pain plus Liangmen (ST21), Neiguan (PC6), Gongsun (SP4). Patient with dyspepsia 
should add Hegu (LI4), Tian shu (ST25), Guanyuan (ST34), Sanyinjiao (SP6). Patient 
with Qi stagnation and blood stasis syndrome should add Taichong (LR4), Xuehai 
(SP10), Hegu (LI4). Patient with qi deficiency and blood stasis syndrome should 
add Xuehai (SP10) and Geshu (BL17). Acupuncture was used for patient with excess 
syndrome and moxibustion for those with deficiency syndrome. Patient with inter-
mingled deficiency and excess syndrome, acupuncture should combine moxibustion.
6.6 Psychological intervention
Mental stimulation is an important factor causing chronic gastritis, and the 
scores of anxiety and depression of patients with chronic gastritis are also higher 
than normal people. Common psychological disorders include loss of confidence in 
treatment, fear of cancer, and fear of special examinations. Strengthening psycho-
logical counseling for gastritis patients is helpful for alleviating the incidence of 
chronic gastritis, alleviating symptoms, and improving the quality of life [25–27].
7. Criterion of therapeutic effect
7.1  The criteria of therapeutic effect of chronic gastritis include evaluation of 
syndrome efficacy, symptom evaluation, endoscopic evaluation of gastric 
mucosa, histopathological evaluation, and evaluation of quality of life
7.1.1 Evaluation of syndrome efficacy
It reflects the characteristics of clinical efficacy evaluation of TCM, and the effi-
cacy is often evaluated by nimodipine method according to the clinical symptoms 
and manifestations of the tongue and pulse. Clinical recovery: The main symptoms 
and signs disappear or almost disappear, and the curative effect index was equal or 
greater than 95%. Significant efficacy: The main symptoms and signs were signifi-
cantly improved, and curative effect index was equal or greater than 70% or smaller 
than 95%. Clinical effective: The main symptoms and signs improved, and curative 
effect index was equal or greater than 30% or smaller than 70%. Ineffectiveness: 
The main symptoms and signs have no obvious improvement or even worse, cura-
tive effect index or smaller than 70%.
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7.1.2 Symptom evaluation
It is mainly aimed at the evaluation of dyspepsia symptoms of chronic gastritis, 
such as upper abdominal pain, fullness or early fullness, loss of appetite, etc. The 
method was that the symptoms were classified into main symptoms and minor 
symptoms according to degree and frequency and assign the value according to the 
weight function, further specification was needed.
7.1.3 Endoscopic evaluation of gastric mucosa
Level I: Branch of Digestive endoscopy of Chinese Medical Association [28] 
Scattered or discontinuous linear erythema, single erosion, local mucosal hemor-
rhage, granular gastric mucosal atrophy, partial visible blood vessel, or single gray 
nodules of intestinal metaplasia. Level II: Dense or continuous linear erythema, 
more than five local multiple erosion, multiple mucosal hemorrhage, medium 
gastric mucosal atrophy, continuous visible blood vessel, or multiple gray nodules 
of intestinal metaplasia. Level III: Extensive fused erythema, more than five exten-
sive multiple erosion, diffuse mucosal hemorrhage, big gastric mucosal atrophy, 
disappeared mucosal folds, visible blood vessel to mucosa surface, or diffused gray 
nodules of intestinal metaplasia.
7.1.4 Histopathological evaluation
It includes mucosal trophy, intestinal metaplasia, intraepithelial neoplasia, 
inflammatory response, and disease activity. They were divided to none, mild 
level, medium level, and severe level [10]. None level: There are no more than 
five mononuclear cells in each high-power field. Mild level: There are a few 
neutrophils in the lamina propria of the gastric mucosa. Chronic inflammatory 
cells are few and limited to the superficial mucosa, no more than one third of the 
mucosa. The number of proper mucosal glands decreased by no more than one 
third of the original glands. Intestinal metaplasia accounts for less than one third 
of the total glandular and surface epithelial area. Medium level: Neutrophils are 
more common in the mucosa and can be found in surface epithelial cells, small 
concave epithelial cells, or glandular epithelium. Chronic inflammatory cells 
are relatively dense, no more than two thirds of the mucosal layer. The number 
of proper mucosal glands decreased between one third and two thirds of the 
original glands. Intestinal metaplasia accounts for one third-two thirds of the 
total glandular and surface epithelial area. Severe level: The neutrophils are 
more dense, or pit abscesses may be seen in addition to the medium. Chronic 
inflammatory cells are dense and occupy the entire mucosal layer. The number 
of proper glands decreased by more than two thirds, and only a few glands 
remained or even disappeared completely. Intestinal metaplasia accounts for 
more than two thirds of the total glandular and epithelial surface area. The visual 
analogue scoring method combined with histopathological evaluation can be 
referred to for grading of each lesion.
7.1.5 Evaluation of quality of life
The patient reported outcomes (PRO), and SF-36 health questionnaire scales 
can be used to evaluate the quality of life. PRO proceeds from the characteristics 
of TCM treatment of spleen and stomach diseases. Patients were evaluated from 
six dimensions including dyspepsia, reflux, defecation, social, psychological, and 
general state [29, 30].
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7.1.6 Anxiety and depression evaluation
Hospital anxiety and depression scale (HAD), anxiety self-rating scale (SAS), 
and depression self-rating scale (SDS) can be used to evaluate the state of anxiety 
and depression.
7.2 Long-term efficacy
Clinical efficacy evaluation of chronic gastritis should combine short-term 
efficacy with long-term efficacy evaluation. The course of chronic gastritis is a long-
term, chronic, and repeated process. In addition to symptoms, atrophy, intestinal 
metaplasia, intraepithelial neoplasia, and other lesions should be the important 
content of observation. The clinical efficacy evaluation time of chronic gastritis is 
recommended to be more than 3 months in order to accurately evaluate the efficacy. 
Long-term follow-up was conducted after the treatment to observe the incidence of 
gastric cancer and other endpoint outcome indicators and disease recurrence.
7.3 Marking targeting biopsy
Marking targeting biopsy of gastric mucosa is of high value for the evaluation of 
chronic atrophic gastritis and chronic atrophic gastritis with intestinal metaplasia 
and intraepithelial neoplasia.
8. Prevention and maintenance
8.1 Alimentary control
Research on the relationship between eating behavior and chronic gastritis 
shows that habits of irregular meals, eating too fast, overeating, eating hot food, 
eating and drinking too much, salty taste are risk factors for chronic gastritis 
[29, 30]. Chronic gastritis patients should try to avoid taking stimulating food, such 
as spicy food, food containing nitrite, etc., and drugs, such as nonsteroidal anti-
inflammatory drugs, that may damage the gastric mucosa.
8.2 Psychological adjustment
Patients with chronic gastritis should keep a good mood and avoid the stimula-
tion of bad emotions. If necessary, they can consult a psychologist.
8.3 Lifestyle adjustment
Patients with chronic gastritis should avoid long-term overwork. In winter and 
spring, we need to pay special attention to life adjustment.
8.4 Follow-up monitoring
Patients with chronic atrophic gastritis accompanied by intraepithelial neo-
plasia and intestinal metaplasia were followed up and monitored to have a certain 
probability of cancer. Studies have shown that the time required for 95% of the 
population with precancerous lesions to become cancerous is 11.6 years for atrophic 
gastritis, 11.4 years for intestinal metaplasia, 5.7 years for dysplasia, and 4.5 years 
for moderate to severe intestinal metaplasia with moderate to severe dysplasia [31].  
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So, the advice of “Chronic gastritis consensus in China” is patients of chronic 
atrophic gastritis with moderate to severe atrophy and intestinal metaplasia need 
around 1-year follow-up. Patients of chronic atrophic gastritis without intestinal 
metaplasia or intraepithelial neoplasia need appropriate follow-up of endoscopy 
and pathology. Patient accompanied by low-level intraepithelial neoplasia and 
proved that it doesn’t come from adjacent tissues of cancer need once endoscopy 
every 3 months follow-up according to the endoscopic and clinical situation. 
However, high-grade intraepithelial neoplasia requires immediate confirmation and 
endoscopic or surgical treatment after confirmation.
9. Conclusions
The core contents of traditional Chinese medicine (TCM) theory are holism 
concept and syndrome differentiation; the treatment based on syndrome dif-
ferentiation is the basic principle of TCM in understanding and treating diseases. 
So based on the treatment of Helicobacter pylori infection, chronic gastritis was 
treated by Chinese medicine based on disease differentiation. Patients with differ-
ent syndromes are treated differently with different medicines. Usually, Chinese 
medicine to treat chronic gastritis is administered orally in decoction or proprietary 
Chinese medicine. In the recent years, improvement of gastritis drug dosage forms 
appeared [32], and it was a modern directed drug release preparation with gastric 
organ flotation and adhesion functions, but more clinical evidence of its effective-
ness is lacking.
In conclusion, TCM plays a certain role in improving the clinical symptoms and 
signs of chronic gastritis. Although the mechanism of its action is not very clear, it 
still has important clinical value and needs further research and discussion.
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